OrbiMed’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,322,300
| Closed | -$32.2M | – | 184 |
|
|
2021
Q2 | $32.2M | Buy |
3,322,300
+157,100
| +5% | +$1.52M | 0.33% | 75 |
|
|
2021
Q1 | $34M | Buy |
3,165,200
+205,000
| +7% | +$2.2M | 0.32% | 76 |
|
|
2020
Q4 | $43.5M | Buy |
2,960,200
+1,707,600
| +136% | +$25.1M | 0.38% | 65 |
|
|
2020
Q3 | $17.8M | Buy |
1,252,600
+41,600
| +3% | +$591K | 0.22% | 87 |
|
|
2020
Q2 | $9.8M | Buy |
1,211,000
+410,000
| +51% | +$3.32M | 0.14% | 99 |
|
|
2020
Q1 | $3.24M | Buy |
+801,000
| New | +$3.24M | 0.05% | 112 |
|